Heghine Khachatryan on ITP’s Key Research Gaps: Biomarkers, Fatigue and Thrombosis Risk
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared a post by ITP Support Association on LinkedIn:
“One important research priority in ITP is understanding disease heterogeneity and treatment response.
Which immunological and clinical biomarkers can predict progression to chronic or refractory ITP and guide personalized therapy (steroids, TPO-RAs, rituximab, fostamatinib)?
In addition, fatigue remains a major unmet need in ITP and often persists despite adequate platelet counts. Understanding its inflammatory and immune mechanisms would have a major impact on patient quality of life.
Finally, the balance between bleeding and thrombosis risk in ITP—especially in patients treated with TPO-receptor agonists and during pregnancy—requires further real-world and prospective studies.”
Quoting ITP Support Association’s post:
“Got an idea for ITP research?
We’ve funded studies on fatigue, pregnancy, MRI, bone marrow, and more. Now we want YOUR input!
What should researchers explore next in ITP?
Drop your ideas in the comments below You can also email your ideas for research to [email protected] and we will collate all the responses from the comments and emails and discuss with our medical advisory team.”

Stay updated and find more posts featuring Heghine Khachatryan on Hemostasis Today.
-
Nov 15, 2026, 23:44Pablo César Spada: Prevention of Venous Thromboembolism After Total Hip or Knee Replacement
-
Nov 15, 2026, 23:30Eshal Amir: Factor XI Inhibitors in AFib and Aortic Mortality Trends
-
Nov 15, 2026, 23:19Hamza Bashir: Adding Endovascular Therapy to Anticoagulation Cuts Moderate-to-Severe PTS in Half
-
Nov 15, 2026, 23:06Lanre Tunji-Ajayi: 2 Days of Deliberative Dialogue Hosted by the Network of Rare Blood Disorder Organizations
-
Nov 15, 2026, 23:00Fanny Delettre: Looking Back at Volunteer Blood Donor Friends Day
-
Nov 15, 2026, 20:56Victoria Adedoyin Adisa-Thomas: What I Learned About SCD During My Genetic Counselling Rotation
-
Nov 15, 2026, 20:55Martin Holst Lange: One Step Closer to a Potential New Treatment for Sickle Cell Disease
-
Nov 15, 2026, 20:53Bontha Babu: Health-Related Quality of Life Among Adults with Sickle Cell Disease in India
-
Nov 15, 2026, 20:52Miguel Ángel Herrera Rojas: A First-Line ITP Approach Presented at ASH in 2013 Now Reflected in the 2026 Guidelines